Maria Yolanda Cervantes-Apolinar
Overview
Explore the profile of Maria Yolanda Cervantes-Apolinar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cervantes-Apolinar M, Guzman-Holst A, Mascarenas De Los Santos A, Macias Hernandez A, Cabrera A, Lara-Solares A, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39772101
Herpes zoster (HZ) is a common disease in older adults and immunocompromised patients, and is frequently associated with long-term complications that impact quality of life. Fortunately, more than one vaccine...
2.
Guzman-Holst A, Cervantes-Apolinar M, Favila J, Huerta-Garcia G
Infect Dis Ther
. 2022 Nov;
12(1):131-141.
PMID: 36348227
Introduction: The risk of herpes zoster (HZ) increases with age. In countries with an ageing population such as Mexico, a rise in the risk of HZ and complications is expected....
3.
Chacon-Cruz E, Lopatynsky-Reyes E, Huerta-Garcia G, Cervantes-Apolinar M, Guzman-Holst A, Van Oorschot D
Hum Vaccin Immunother
. 2022 Aug;
18(6):2103319.
PMID: 35921223
Invasive meningococcal disease (IMD) is an uncommon but serious and potentially fatal condition mainly affecting children and adolescents. Active surveillance between 2005 and 2016 at Tijuana General Hospital, Mexico, indicated...
4.
Guzman-Holst A, Luna-Casas G, Burguete Garcia A, Madrid-Marina V, Cervantes-Apolinar M, Andani A, et al.
PLoS One
. 2022 May;
17(5):e0268469.
PMID: 35584365
Background: Hepatitis A virus (HAV) infection is a leading cause of viral hepatitis in children, yet the HAV vaccine is not included in the national immunization program (NIP) in Mexico....
5.
Guzman-Holst A, Ortega-Barria E, Flores A, Carreno-Manjarrez R, Constenla D, Cervantes-Apolinar M
Hum Vaccin Immunother
. 2021 Jun;
17(10):3623-3637.
PMID: 34187326
A systematic review was conducted in Mexico to consolidate and evaluate evidence after 15 years of rotavirus vaccination, according to the National Immunization Program. Five databases were screened to identify...
6.
Mascarenas De Los Santos A, Rodriguez-Weber M, Sanchez-Marquez P, Traskine M, Carreno-Manjarrez R, Cervantes-Apolinar M, et al.
Expert Rev Vaccines
. 2020 Dec;
19(11):995-1010.
PMID: 33297773
We assessed the safety and immunogenicity of 2 + 1 infant regimens initiated with the 13-valent pneumococcal conjugate vaccine (PCV13) and completed with the pneumococcal non-typeable protein D-conjugate vaccine (PHiD-CV)....
7.
Lopez-Gatell H, Garcia-Garcia L, Echaniz-Aviles G, Cruz-Hervert P, Olamendi-Portugal M, Castaneda-Desales D, et al.
Hum Vaccin Immunother
. 2018 Nov;
15(2):433-439.
PMID: 30380981
Objectives: To estimate hepatitis B virus (HBV) seroprevalence from natural infection or vaccination in 10-25-year-olds in Mexico, using the 2012 National Health and Nutrition Survey (ENSANUT). Methods: Randomly selected serum...
8.
Luna-Casas G, Juliao P, Carreno-Manjarrez R, Castaneda-Prado A, Cervantes-Apolinar M, Navarro-Rodriguez R, et al.
Hum Vaccin Immunother
. 2018 Nov;
15(6):1251-1259.
PMID: 30380975
Worldwide, rotavirus infection has been a leading cause of severe diarrhea morbidity and mortality. Two rotavirus vaccines have been used in the National Immunization Program (NIP) in Mexico; two-dose from...
9.
Lopez-Gatell H, Garcia-Garcia L, Echaniz-Aviles G, Cruz-Hervert P, Olamendi-Portugal M, Castaneda-Desales D, et al.
Vaccine
. 2018 Oct;
36(52):8094-8099.
PMID: 30337174
To describe hepatitis A virus (HAV) seroprevalence and associated factors in adolescents (10-19 years) and young adults (20-25 years) in different Mexican regions, using 2012 National Health and Nutrition Survey...
10.
Cortes-Alcala R, Dos Santos G, DeAntonio R, Devadiga R, Ruiz-Matus C, Jimenez-Corona M, et al.
Hum Vaccin Immunother
. 2018 May;
14(8):1890-1898.
PMID: 29746798
Despite vaccination programs, influenza still represents a significant disease burden in Mexico. We conducted an observational, retrospective analysis to better understand the epidemiological situation of the influenza virus in Mexico....